Oncology
Detection of HER2-positive circulating tumor cells and circulating endothelial cells in an ancillary study of the BEVERLY2 multicenter phase II trial of neoadjuvant chemotherapy combined with Trastuzumab and §Bevacizumab in HER2-overexpressing inflammatory breast cancer
Read more